1. P564 vedolizumab versus infliximab and adalimumab in the real-world persistence in Ulcerative Colitis and Crohn's disease – a meta-analysis. (30th January 2023) Authors: Yiu, T H; Leong, R; Ko, Y; Pudipeddi, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗